REVERSING PRE-DABETES USING FUSION PROTEINS COMPRISING A GAD PEPTIDE
暂无分享,去创建一个
[1] K. Legge,et al. On the Role of Dendritic Cells in Peripheral T Cell Tolerance and Modulation of Autoimmunity , 2002, The Journal of experimental medicine.
[2] D. Wegmann,et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. , 2002, Diabetes.
[3] Meng Chen,et al. Suppression of Autoimmune Diabetes by Viral IL-10 Gene Transfer1 , 2002, The Journal of Immunology.
[4] David F. Richards,et al. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.
[5] A. Cooke,et al. Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes1 , 2001, The Journal of Immunology.
[6] E. Bonifacio,et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. , 2001, Diabetes.
[7] M. Roncarolo,et al. Type 1 T regulatory cells , 2001, Immunological reviews.
[8] R. Flavell,et al. A Dual Role for TNF-α in Type 1 Diabetes: Islet-Specific Expression Abrogates the Ongoing Autoimmune Process When Induced Late but Not Early During Pathogenesis1 , 2001, The Journal of Immunology.
[9] W. Suarez-Pinzon,et al. Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation1 , 2001, The Journal of Immunology.
[10] K. Legge,et al. Multi-Modal Antigen Specific Therapy for Autoimmunity , 2001, International reviews of immunology.
[11] Asaf Rotem,et al. Vaccination with Empty Plasmid DNA or CpG Oligonucleotide Inhibits Diabetes in Nonobese Diabetic Mice: Modulation of Spontaneous 60-kDa Heat Shock Protein Autoimmunity1 , 2000, The Journal of Immunology.
[12] K. Legge,et al. Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Myelin-Activated T Cells and Ameliorates Experimental Allergic Encephalomyelitis , 2000, The Journal of experimental medicine.
[13] E. Unanue,et al. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.
[14] M. Rewers,et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Cooke,et al. Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes. , 1999, Diabetes.
[16] H. Y. Song,et al. Human insulin B chain but not A chain decreases the rate of diabetes in BB rats. , 1999, Diabetes research and clinical practice.
[17] Fiona Powrie,et al. An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation , 1999, The Journal of experimental medicine.
[18] P. Nickerson,et al. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice. , 1999, Journal of immunology.
[19] K. Legge,et al. Neonatal Exposure to a Self-Peptide–Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon γ–mediated Splenic Anergy , 1998, The Journal of experimental medicine.
[20] Jonathan M. Austyn,et al. Dendritic cells , 1998, Current opinion in hematology.
[21] C. Benoist,et al. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] Bhagirath Singh,et al. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.
[23] P. Nickerson,et al. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. , 1997, Journal of immunology.
[24] K. Legge,et al. Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing , 1997, The Journal of experimental medicine.
[25] N. Sarvetnick,et al. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity , 1996, The Journal of experimental medicine.
[26] D. Scott,et al. Epitope-specific tolerance induction with an engineered immunoglobulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Tisch,et al. Insulin-Dependent Diabetes Mellitus , 1996, Cell.
[28] N. Sarvetnick,et al. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. , 1996, Journal of autoimmunity.
[29] C. Benoist,et al. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Wegmann,et al. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] F. Lepault,et al. Isolation of leukocytes infiltrating the islets of Langerhans of diabetes-prone mice for flow cytometric analysis. , 1995, Journal of immunological methods.
[32] D. Wegmann,et al. Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.
[33] J. Bach,et al. Insulin-dependent diabetes mellitus as an autoimmune disease. , 1994, Endocrine reviews.
[34] M. Monahan,et al. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. , 1994, Clinical immunology and immunopathology.
[35] N. Sarvetnick,et al. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice , 1994, The Journal of experimental medicine.
[36] R. Steinman,et al. Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus , 1993, The Journal of experimental medicine.
[37] R. Steinman,et al. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. , 1993, Science.
[38] J. Feder,et al. Thermal properties of human IgG. , 1987, Molecular immunology.
[39] Y. Tochino,et al. Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.
[40] G. Eisenbarth,et al. Insulin-specific tolerance in diabetes. , 2002, Clinical immunology.
[41] A. Bot,et al. Diabetic Mice Prevents Autoimmune Diabetes in Nonobese Plasmid Vaccination with Insulin B Chain , 2001 .
[42] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[43] K. Buschard,et al. the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. Printed in Malaysia. Neonatal Treatment with Beta-cell Stimulatory Agents Reduces the Incidence of Diabetes in BB Rats , 1999 .
[44] H. Mcdevitt,et al. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. , 1995, Immunology today.
[45] M. Erlander,et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[46] G. Eisenbarth,et al. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.
[47] N. Sarvetnick,et al. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. , 1990, Nature.